Navigation Links
Injection supports Heart Devices

According to a new study a clot-buster injection may unclog a mechanical heart pump, reconditioning the blood flow. Markus Rothenburger, M.D., researcher from University Hospital in Germany,// felt that this is a simple solution to a very serious problem for heart failure patients who receive left ventricular assist devices.

A left ventricular assist device is a mechanical pump-like device that is surgically implanted to maintain the pumping ability of a heart that can't dynamically work on its own. Clot-busting drugs, known as thrombolytic therapy, dissolve blood clots that impair blood flow.

The device used in the study, the recently introduced MicroMed DeBakey VAD, differs from other LVADs in that it generates a continuous blood flow rather than a pulsing one. The advantage over similar devices is smaller size and less noise. Researchers felt that the smaller size seems to have reduced the incidence of thromboembolism, or a blood clot that moves through the blood stream before blocking an artery.

Researchers studied 20 patients who used the MicroMed DeBakey VAD. The pump flow was critically reduced in eight patients. Dr. Rothenburger felt that despite these advances, [the device's] axial pump seems to be associated with a higher risk for clot formation, which then might cause device malfunction and peripheral thromboembolism. He added , however, that this serious complication can be treated dynamically and an exchange of the device would not be essential.


'"/>




Page: 1

Related medicine news :

1. Abstinence From Alcohol With The Help Of An Injection
2. Unsafe Injections and Unclean Hand hygiene major cause of hospital infections in India
3. Leptin Injections Maintain Loss In Body Weight
4. FDA Approves Novel Creation of Imitrex? Injection for Migraine
5. Needle-Free Injection System Ideal for Pandemic Outbreaks
6. Breast Enlargement Injections Can Lead To Breast Loss
7. Flying Injection: Prevent the bite of disease
8. Orchid gets FDA Approval for Cefotaxime Injections
9. Lowering Contrast Material Injection in Aged Patients is Cost-effective and can Offset Risks
10. In Elderly Patients Lowering Contrast Material Injection Will Reduce Costs
11. Two Children Die After Administering DPT Injection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... Spain (PRWEB) , ... April 24, 2017 , ... ... on the development of next generation neuro-thrombectomy systems for the treatment of Acute ... and manufacture its ANCD BRAIN device as the product advances towards regulatory and ...
(Date:4/23/2017)... ... 2017 , ... "An event Horizon is a place where the laws of ... and Music. These are created as Metaphysical Transformations where music, which is the origin ... the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview her upcoming ...
(Date:4/22/2017)... ... ... Ecommerce sales have grown every year since the 1990’s, with 2016 retail ... of rapid innovation and growth are often neglected in the name of progress. As ... individual’s job to give something back to the planet that provides the resources needed ...
(Date:4/22/2017)... White Plains, NY (PRWEB) , ... April 22, ... ... Quarterly Report, which shows that U.S. consumers can save an average of 70% ... Even greater savings (up to 97%) are available when purchasing from other countries. ...
(Date:4/22/2017)... Capistrano (PRWEB) , ... April 22, 2017 , ... The San Juan Capistrano summer ... released a parenting report outlining the need for summer camps to provide physical activities for ... Importance of Physical Activity In Summer Camps , With an increase in specialty camps that ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... April 18, 2017 Cogentix Medical, Inc. (NASDAQ: ... the Urology, Uro/Gyn and Gynecology markets with innovative and ... quarter ended March 31, 2017 after the market close ... Company will host a conference call and webcast to ... May 2, 2017 at 4:30 p.m. Eastern Time (3:30 ...
Breaking Medicine Technology: